he characteristic hemodynamic change in nonobstructive hypertrophic cardiomyopathy (HCM) is left ventricular (LV) diastolic dysfunction, and it has been reported that diastolic dysfunction is an important factor determining exercise limitation in patients with HCM. 1 Conversely, it is believed that myocardial ischemia commonly occurs in patients with HCM and patent epicardial coronary arteries. 2 Myocardial ischemia or impaired contractility that is independent of myocardial ischemia may cause systolic dysfunction.
Methods

Patients
The study group consisted of 56 patients with nonobstructive HCM and 12 control subjects. The diagnosis of HCM was based on an echocardiographic demonstration of a non-dilated, hypertrophied left ventricle in the absence of other cardiac or systemic causes for LV hypertrophy. 8 Patients with any of the following findings were excluded from the study as they were considered to have obstructive HCM: (i) echocardiographic evidence of systolic anterior motion of the mitral valve and/or midsystolic closure of the aortic valve; (ii) a pressure gradient ≥20 mmHg in the outflow tract or midportion of the left, right, or both ventricles at baseline; and (iii) a peak gradient ≥30 mmHg after provocative maneuvers (Valsalva maneuver, BrockenbroughBraunwald phenomenon, 9 or dobutamine stress). Patients with atrial fibrillation, left bundle branch block, valvular heart disease, diabetes mellitus, or hypertension were also excluded from the study. The control group consisted of 12 individuals who underwent cardiac evaluation because of atypical chest symptoms but had no evidence of abnormalities. Fifty of the 56 patients with HCM and 10 of the 12 control patients underwent cardiac catheterization and coronary angiography (CAG), and had no evidence of coronary artery stenosis. The remaining 6 patients with HCM and 2 control patients did not undergo CAG, but all were younger than 50 years of age and unlikely to have significant coronary stenoses. Informed consent was obtained from each patient before the study.
Radionuclide Studies
All medications were discontinued at least 24 h before the study. Left ventricular function was evaluated using a radio- nuclide continuous ventricular function monitor equipped with a cadmium telluride detector (CdTe-VEST RRG-607; Aloka, Tokyo, Japan). VEST studies were performed using a protocol described elsewhere. 10, 11 After equilibration of 740 to 925 MBq of 99m Tc-labeled red blood cells with the blood pool, the vest-like elastic garment was placed over the chest. With the patient in the supine position, the CdTe detector was placed over the left ventricular blood pool using gamma camera visualization in the left anterior oblique position.
Exercise Stress
After 5 min of rest, supine bicycle ergometer exercise was initiated at a workload of 25 W and increased by 25 W every 2 min. Systolic and diastolic blood pressures were measured with a sphygmomanometer (STBP-680; NIPPON COLIN Co, Tokyo, Japan) at 1 min intervals during the test. After completion of the study, the position of the detector was reconfirmed with a 20 s static image obtained with the gamma camera.
VEST Data Analysis
VEST data analysis has been published elsewhere. 6, 7 In brief, after the decay-corrected LV time -activity curve (50 ms sequential acquisitions) was smoothed by digital filtering, the EF was calculated as the difference between the enddiastolic and end-systolic counts divided by the backgroundcorrected end-diastolic counts for each beat and averaged for 20 s intervals. The maximum and minimum counts from the LV time -activity curve were defined as the end-diastolic and end-systolic counts, respectively. The relative enddiastolic volume was defined as 100% at the beginning of the study and subsequent measurements were expressed relative to this value. Parameters were calculated as follows:
Cardiac output (CO) = Stroke volume × Heart rate, Mean blood pressure = 1/3 (Systolic blood pressureDiastolic blood pressure) + Diastolic blood pressure, Systemic vascular resistance (SVR) = Mean blood pressure / Cardiac output.
Based on the changes in LVEF, 6 patients with HCM were divided into 2 groups: (i) group A either had no significant change in EF (±5% of the resting EF) or >5% increase in EF during exercise ( Fig 1A) ; and (ii) group B had >5% decrease in EF during exercise (Fig 1B) .
Echocardiographic Examination
A transthoracic echocardiographic examination was performed in all patients within 1 week of the VEST study. Standard M-mode and 2-dimensional echocardiographic studies were performed to identify and quantify the morphologic features of the LV. Left ventricle dimensions and the thicknesses of the septum and LV posterior wall were measured at the level of the tips of the mitral valve leaflets. The fractional shortening was calculated as the difference in end-diastolic and end-systolic dimensions divided by the end-diastolic dimension.
Statistical Analysis
Values are expressed as the mean ± SD. Comparisons between groups were performed using one-way analysis of variance (ANOVA) followed by Scheffe's method. Categorical data were compared using chi-square analysis. To compare responses between groups, a 2-way repeated measures ANOVA was used. Correlation was assessed by linear regression analysis and Pearson's correlation coefficient. A p value <0.05 was considered statistically significant.
Results
Baseline Characteristics
The clinical and echocardiographic features of the study groups are summarized in Table 1 . The proportion of women, the incidence of a family history of sudden cardiac death, and New York Heart Association functional class were all higher in group B than in group A. Interventricular septal thickness (IVST), LV posterior wall thickness (PWT), IVST/PWT ratio, and left atrial dimension were significantly greater in groups A and B than in the control group, but did not differ significantly between groups A and B.
Hemodynamic Changes During Supine Ergometer Exercise
Exercise was terminated because of chest pain in one patient in group B, and because of dyspnea and leg fatigue in the remaining patients in groups B and A, and the control group. The exercise duration was significantly shorter in group B than in group A ( Table 2) . Hemodynamic parameters at rest did not differ between the 3 groups. During exercise, systolic blood pressure (SBP), diastolic blood pressure, heart rate, and rate-pressure product increased in all 3 groups. However, a difference was observed in the SBP response in the 3 groups (Table 2) , and the change in SBP in group B was smaller than that in the control group (Fig 1A) group A and (Fig 1B) and group A (Table 3, Fig 2) .
The EF in the control group, group A and group B changed from 0.62±0.07 to 0.78±0.09, from 0.66±0.08 to 0.72±0.09 and from 0.68±0.09 to 0.52±0.14, respectively. The LV end-diastolic volume (EDV) increased to a similar extent in all 3 groups during exercise. In contrast, the change in end-systolic volume (ESV) was statistically different in the 3 groups (p<0.0001).
Changes in EF (∆EF) and changes in SBP (∆SBP) between rest and peak exercise showed a positive correlation, as shown in Fig 3. In addition, changes in EF and changes in CO between rest and peak exercise also showed a good positive correlation (y = 125 + 2.00x; r=0.773, p<0.0001). Changes in EF and changes in SVR between rest and peak exercise showed a negative correlation, as shown in Fig 4. Changes in SVR and changes in SBP between rest and peak exercise did not show a significant correlation.
Discussion
In the present study, we demonstrated that the change in SBP was smaller in patients with HCM whose EF decreased during exercise than in patients whose EF did not decrease, and that changes in EF during exercise correlated with changes in SBP.
Abnormal blood pressure response during exercise are well described in patients with HCM and are believed to result from abnormal vascular responses 3,4 or myocardial ischemia. 5 A decrease in EF caused by systolic dysfunction reduces the stroke volume, and may attenuate the increases in cardiac output and blood pressure during exercise. Therefore, we hypothesized that systolic dysfunction may be associated with abnormal blood pressure response in patients with HCM. In the present study, there were significant differences in the changes in SBP during exercise between the 3 groups, and a positive correlation was observed between the changes in EF and SBP during exercise. In addition, an increase in CO during exercise in group B was smaller than that in the control group and group A, and a positive correlation was also observed between the changes in EF and CO during exercise. From these results, we hypothesize that the decrease in EF during exercise observed in group B may have resulted in smaller increases in CO and SBP than in the control group and group A. In contrast, a good negative correlation was observed between the changes in EF and SVR during exer- cise. This finding suggests that peripheral compensatory mechanisms function in these patients. However, it is hypothesized that the mechanisms are inadequate to compensate for a decrease in CO and to generate an increase in SBP in group B. These results suggest that systolic dysfunction may be one of determinants of abnormal blood pressure response in patients with HCM. The SBP response during upright exercise in patients with HCM may differ from supine exercise because of decreases in the preload. However, we did not evaluate the hemodynamic responses to upright exercise in the present study because of methodological concerns.
The possible causes of a decrease in EF during exercise include LV outflow tract obstruction, myocardial ischemia, and impaired contractility. Left ventricular outflow tract obstruction may increase ESV and decrease EF. To exclude the effects of this factor, we selected patients with nonobstructive HCM for the study. It is believed that myocardial ischemia commonly occurs in patients with HCM and patent epicardial coronary arteries. 2 In the present study, the control group and group A had an increase in EDV, a decrease or no change in ESV, and an increase in EF with exercise. In contrast, group B had a decrease in EF caused by an increase in ESV. The responses in group B are consistent with those seen in ischemic heart disease. 10, 12 In some patients with non-obstructive HCM, a decrease in EF during exercise may be caused by myocardial ischemia occurring predominantly in the hypertrophied myocardium. 7, 13 Further studies are necessary to determine the prognosis of patients with HCM and the failure to increase their EF with exercise.
Study Limitations
Accurate detector positioning is necessary to measure EF reliably. Although a shift of the detector results in significant changes in the EF, all groups would be affected equally by this influence. Moreover, changes in the EF with exercise determined by a gamma camera and VEST have a good correlation. 10 The other factor that may influence EF measurements is heart size. It has been reported that the EF is underestimated when the LV volume is increased. 10 However, we believe that this influence is minimal because the LV cavity size in patients with HCM is relatively small.
Although we selected patients with non-obstructive HCM, LV outflow tract obstruction during exercise cannot be completely excluded. However, there was no significant correlation between EF response and the pressure gradient during dobutamine infusion in a previous study. 13 Therefore, it is unlikely that the pressure gradient affected the EF response during exercise in many patients in the present study.
